NHC Responds to FDA RFI on PFDD Meetings June 30, 2026 Dockets Management Staff (HFA-305) Food and Drug Administration 5630 Fishers Lane, Rm. 1061 Rockville, MD 20852 RE: Impacts of […]
drug development
NHC Responds to CMS Information Collection Request on Drug Price Negotiation
NHC Responds to CMS Information Collection Request on Drug Price Negotiation August 29, 2025 Mehmet Oz, MD, MBA Administrator Centers for Medicare & Medicaid Services Department of Health and Human […]
NHC Comments on Public Meeting on Reauthorization of the Prescription Drug User Fee Act
NHC Comments on Public Meeting on Reauthorization of the Prescription Drug User Fee Act August 14, 2025 Dockets Management Staff (HFA-305) U.S. Food and Drug Administration Division of Dockets Management […]
NHC’s Patient Experience Data Assets: Evidence-based Tools to Improve Patient Health Outcomes
NHC’s Patient Experience Data Assets: Evidence-based tools to improve patient health outcomes By: Omar A. Escontrías, DrPH, MPH, Senior Vice President, Equity, Research & Programs Patient experience data (PED) is […]